Patient population |
Often children |
Typically adults first and children studied only after efficacy established in adults |
Inclusion and exclusion criteria |
Often exclude underweight or malnourished; May exclude those whose usual diet is similar to intervention diet |
Nutrition or usual diet rarely part of inclusion criteria |
Common outcomes |
Disease activity, quality of life, anthropometric parameters |
Disease activity, quality of life |
Concomitant medications |
Determined by study question |
May exclude certain medications to avoid excessive immunosuppression |
Intervention |
Supplementation or exclusion of a dietary component |
Addition or withdrawal of a medication |
Comparator |
Placebo if studying supplement; usual or standard diet if studying dietary pattern |
Placebo or effective therapy |
Randomization |
Essential |
Essential |
Blinding |
Sometimes impossible |
Essential |
Dose finding |
Uncommon |
Based on phase 1 and 2 trials |
Sample size |
Based on minimally important difference |
Based on minimally important difference |
Adherence measurement |
24 hour recalls, food frequency questionnaires, food checklists, and or measurement of biomarkers |
Pill counts, electronic monitoring, direct observation therapy |
Analytic approach |
Intention to treat analysis, with or without additional per protocol analysis |
Intention to treat analysis |
Personnel |
May include plant scientists, food scientists, registered dietitians, educational experts, behavior interventionists |
May include experts in pharmacodynamics and pharmacokinetic measurements |